Fingerprint
Dive into the research topics of 'The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro
Marie N. Becker, Kevin J. Wu, Laura A. Marlow, Pamela A. Kreinest, Christina A. vonRoemeling, John A. Copland, Christopher R. Williams
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations